Trade Summary

5 months ago, Morrison Briggs, serving as Dir at Arvinas, Inc. (ARVN), purchased 30,000 shares at $7.57 per share, for a total transaction value of $227,010.00. Following this transaction, Morrison Briggs now holds 76,021 shares of ARVN.

This purchase represents a 65.00% increase in Morrison Briggs's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, September 22, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, September 24, 2025, 2 days after the trade was made.

Arvinas, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.